TableĀ 3

Predictors of work disability among patients undergoing Hymenoptera venom immunotherapy (VIT), adjusted for gender and age

OR95% CI
Having the severe reaction at work2.3060.9095.852
Workers at high risk of exposure to Hymenoptera2.6551.0446.754
Self-employed workers2.0790.8834.892